The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 17,301–17,400 of 31,469
Association of Genetic Variation in ENPP1 With Obesity‐related Phenotypes
Jenkinson, C. P., Coletta, D. K., Flechtner‐Mors, M., et al. (2008) · Obesity · doi:10.1038/oby.2008.262 · Cited by 16
Wieczorek-Baranowska, A., Nowak, A., & Pilaczyńska-Szczȩśniak, Ł. (2011) · Metabolism · doi:10.1016/j.metabol.2011.08.011 · Cited by 17
Portal and systemic levels of visfatin in morbidly obese subjects undergoing bariatric surgery
Karbaschian, Z., Hosseinzadeh‐Attar, M. J., Giahi, L., Golpaie, A., Masoudkabir, F., Talebpour, M., Kosari, F., Karbaschian, N., Hoseini, M., & Mazaherioun, M. (2012) · Endocrine · doi:10.1007/s12020-012-9821-x · Cited by 16
Insulin resistance and oxidative stress in diabetic rats treated with flaxseed oil
Hussein, J., El-Khayat, Z., Taha, M., et al. (2012) · Journal of Medicinal Plants Research · doi:10.5897/jmpr12.498 · Cited by 16
Tenor, D. P., Berenguer, J., Jiménez‐Sousa, M. Á., et al. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.08.020 · Cited by 16
Hsieh, M., Hsiao, J., Tien, K., Chang, S., Lin, P.-C., Hsu, S.-C., Liang, H., Chen, H., & Lin, S. (2008) · Metabolism · doi:10.1016/j.metabol.2008.03.018 · Cited by 16
Nonesterified Fatty Acids as Mediators of Glucose Intolerance in Indian Asian Populations
Patel, J. V., Vyas, A., Prabhakaran, D., Bhatnagar, D., Durrington, P. N., Heald, A., Hughes, E., Mackness, M., Reddy, K. S., & Cruickshank, J. K. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1505 · Cited by 16
Holland‐Fischer, P., Vilstrup, H., Frystyk, J., Nielsen, D. T., Flyvbjerg, A., & Grønbæk, H. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0971 · Cited by 16
St-Pierre, D. H., Bastard, J., Coderre, L., Brochu, M., Karelis, A. D., Lavoie, M.-È., Malita, F. M., Fontaine, J., Mignault, D., Cianflone, K., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0038 · Cited by 16
Donner, D. G., Elliott, G. E., Beck, B. R., Bulmer, A. C., Lam, A. K.-Y., Headrick, J. P., & Toit, E. F. D. (2015) · Endocrinology · doi:10.1210/en.2015-1603 · Cited by 16
Associations Between Salivary Bone Metabolism Markers and Periodontal Breakdown
Gürsoy, U. K., Liukkonen, J., Jula, A., Huumonen, S., Suominen, A. L., Puukka, P. J., & Könönen, E. (2015) · Journal of Periodontology · doi:10.1902/jop.2015.150399 · Cited by 16
Lakhdar, N., Denguezli, M., Zaouali, M., Zbidi, A., Tabka, Z., & Bouassida, A. (2014) · PubMed · Cited by 16
Insulin sensitivity in type 2 diabetes is closely associated with LDL particle size
Krayenbuehl, P.-A. (2008) · Swiss Medical Weekly · doi:10.4414/smw.2008.12124 · Cited by 16
Honda, T., Kobayashi, Y., Togashi, K., Hasegawa, H., Iwasa, M., Taguchi, O., Takei, Y., & Sumida, Y. (2015) · Nutrition · doi:10.1016/j.nut.2015.11.003 · Cited by 16
Darzi, J., Frost, G. S., Swann, J. R., Costabile, A., & Robertson, M. D. (2015) · Appetite · doi:10.1016/j.appet.2015.12.011 · Cited by 16
The metabolic syndrome in survivors of childhood acute lymphoblastic leukemia in Isfahan, Iran.
Reisi, N., Azhir, A., Hashemipour, M., Raeissi, P., Amini, A., & Moafi, A. (2009) · PubMed Central · Cited by 16
Tubić, B., Magnusson, P., Mårild, S., Leu, M., Theiler‐Schwetz, V., Sioen, I., Herrmann, D., Obermayer-Pietsch, B. M., Lissner, L., & Swolin‐Eide, D. (2016) · Bone · doi:10.1016/j.bone.2016.01.008 · Cited by 17
Çalan, M., Küme, T., Yılmaz, Ö., Arkan, T., Kocabaş, G. Ü., Dokuzlar, Ö., Aygün, K., Oktan, M. A., Danış, N., & Temür, M. (2016) · Endocrine Research · doi:10.3109/07435800.2015.1135442 · Cited by 15
Kasapoğlu, B., Türkay, C., Yalçın, K. S., Çarlıoğlu, A., & Köktener, A. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.178585 · Cited by 16
Chronic pancreatitis and the composition of plasma phosphatidylcholine fatty acids
Zeman, M., Macášek, J., Burda, M., TVRZICKÁ, E., Vecka, M., Krechler, T., Staňková, B., Hrabák, P., & Žák, A. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.03.012 · Cited by 16
Tint, D. (2011) · Journal of Nutritional Disorders & Therapy · doi:10.4172/2161-0509.s7-001 · Cited by 16
Llopis, M., Sánchez, J., Priego, T., Palou, A., & Picó, C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf405161e · Cited by 16
Novel heterozygous IGF1R mutation in two brothers with developing impaired glucose tolerance
Burkhardt, S., Gesing, J. K., Kapellen, T. M., Kovacs, P. L., Kratzsch, J., Schlicke, M., Stobbe, H., Tönjes, A., Klammt, J., & Pfäffle, R. W. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0132 · Cited by 16
Li, X., Zhang, N., Li, Y., Shi, Y., Li, D., Xie, Y., Xie, Y., & Ming, J. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900203 · Cited by 16
Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4
Rizk, H. H., Hamdy, N. Μ., Al-Ansari, N. L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153895 · Cited by 16
Effects of genetic severity on glucose homeostasis in Friedreich ataxia
Isaacs, C. J., Brigatti, K. W., Kucheruk, O., Ratcliffe, S. J., Sciascia, T., McCormack, S. E., Willi, S. M., & Lynch, D. R. (2016) · Muscle & Nerve · doi:10.1002/mus.25136 · Cited by 16
Hitsumoto, T. (2015) · Journal of Nippon Medical School · doi:10.1272/jnms.82.274 · Cited by 16
Lesser, I., Guenette, J., Hoogbruin, A., Mackey, D., Singer, J., Gasevic, D., & Lear, S. (2016) · Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · doi:10.1139/apnm-2016-0082 · Cited by 17
Nagaraju, R., & Rajini, P. S. (2016) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2016.04.009 · Cited by 17
Lukášová, P., Včelák, J., Vaňková, M., Vejražková, D., Andělová, K., & Bendlová, B. (2008) · Physiological Research · doi:10.33549/physiolres.931494 · Cited by 16
Caminiti, G., FOSSATI, C., Battaglia, D., Massaro, R., Rosano, G. M. C., & Volterrani, M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.003 · Cited by 16
Sun, Y., Li, W., Hou, X., Wang, C., Li, C., Zhang, X., Yang, W., Ma, Z., Wang, W., Ning, G., et al. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20140030 · Cited by 16
Myostatin and carbohydrate disturbances
Assyov, Y. S., Velikova, T. V., & Kamenov, Z. A. (2016) · Endocrine Research · doi:10.1080/07435800.2016.1198802 · Cited by 16
Kahraman, F. U., Torun, E., Osmanoğlu, N. K., Oruçlu, Ş., & Özer, Ö. F. (2016) · Pediatrics International · doi:10.1111/ped.13073 · Cited by 16
Grzegorzewska, A. E., Niepolski, L., Mostowska, A., et al. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.07.009 · Cited by 16
Niveles séricos de la adipomioquina irisina en pacientes con enfermedad renal crónica
Rodríguez–Carmona, A., Fontán, M. P., Sangiao‐Alvarellos, S., Falcón, T. G., Bello, M. L. P., Muñíz, A. L., & Cordido, F. (2016) · Nefrología · doi:10.1016/j.nefro.2016.05.019 · Cited by 16
Ahmed, A., Ghany, M. A., Hakeem, G. L. A., Kamal, A., Khattab, R. A., Abdalla, A., Aboul-Fotoh, L. E.-M., Mazary, A. A. E., Sayed, M. A., & Fadil, A. M. A. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0112-z · Cited by 16
Goff, L. M., Whyte, M., Samuel, M., & Harding, S. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0315-3 · Cited by 16
Liang, Z., Qiu, Q. Y., Wu, J. H., Zhou, J. W., Xu, T., Zhang, M. Z., Zhang, Y., & Zhang, S. Y. (2016) · PubMed · doi:10.3967/bes2016.074 · Cited by 16
Fukuoka, C. Y., Schröter, G. T., Nicolau, J. C., & Simões, A. (2016) · Journal of Biophotonics · doi:10.1002/jbio.201600175 · Cited by 16
Kim, G., Lee, Y., Jeon, J. Y., Bang, H., Lee, B., Kang, E. S., Lee, I. K., Cha, B.-S., & Kim, C. S. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.09.002 · Cited by 16
Effect of curative parathyroidectomy on insulin resistance
Putnam, R., Dhibar, D. P., Varshney, S., Behera, A., Mittal, B. R., Bhansali, A., Rao, S. D., & Bhadada, S. K. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.192916 · Cited by 16
Mispireta, M. L., Caulfield, L. E., Zavaleta, N., Merialdi, M., Putnick, D. L., Bornstein, M. H., & DiPietro, J. A. (2016) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174416000568 · Cited by 16
Brinkley, T. E., Leng, X., Nicklas, B. J., Kritchevsky, S. B., Ding, J., Kitzman, D. W., & Hundley, W. G. (2017) · Metabolism · doi:10.1016/j.metabol.2017.02.008 · Cited by 16
Cooper, S. B., Dring, K. J., Morris, J. G., Cousins, B. E. W., Nute, M. L., & Nevill, M. E. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517000447 · Cited by 16
Yıldırım, E., Karabulut, O., Yüksel, U. Ç., Çeli̇k, M., Buğan, B., Gökoğlan, Y., Ulubay, M., Güngör, M., & Köklü, M. (2017) · Cardiology Journal · doi:10.5603/cj.a2017.0032 · Cited by 17
Rijks, J. H. J., Plat, J., Dorenbos, E., Penders, B., Gerver, W. M., & Vreugdenhil, A. C. E. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3057 · Cited by 16
Damanti, S., Bourron, O., Doulazmi, M., Sosso, A.-L. M., Nguyen‐Michel, V., Mariani, J., & Kinugawa, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174876 · Cited by 16
Miranda‐Lora, A. L., Cruz, M., Aguirre‐Hernández, J., Molina‐Díaz, M., Padilla‐Gutiérrez, J. R., Flores‐Huerta, S., & Klünder‐Klünder, M. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0987-9 · Cited by 17
Schelp, A. O., Mendes-Chiloff, C. L., Paduan, V. C., Corrente, J. E., Vieira, A., Marchette, J. C. N., de Souza, J. T., Luvizutto, G. J., Nogueira, C. R., & Bazán, R. (2017) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2017.03.006 · Cited by 16
Markers of inflammation and cardiovascular disease in recently diagnosed celiac disease patients
Tetzlaff, W., Meroño, T., Menafra, M., Martín, M., Botta, E., Matoso, M. D., Sorroche, P. B., Paula, J. A. D., Boero, L. E., & Brites, F. D. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i5.448 · Cited by 16
Sedentary Behaviors and Biomarkers Among Breast Cancer Survivors
Hartman, S. J., Marinac, C. R., Cadmus‐Bertram, L., Kerr, J., Natarajan, L., Godbole, S. V., Patterson, R. E., Morey, B. L., & Sears, D. D. (2017) · Journal of Physical Activity and Health · doi:10.1123/jpah.2017-0045 · Cited by 16
Choo, M. S., Choi, S. R., Han, J. H., Lee, S. H., & Shim, Y. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177311 · Cited by 16
Kininase 1 As a Preclinical Therapeutic Target for Kinin B1 Receptor in Insulin Resistance
Haddad, Y., & Couture, R. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00509 · Cited by 16
Gorostegi-Anduaga, I., Corres, P., Jurio-Iriarte, B., et al. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1346111 · Cited by 16
Kono, S., Adachi, H., Enomoto, M., Fukami, A., Kumagai, E., Nakamura, S., Nohara, Y., Morikawa, N., Nakao, E., Sakaue, A., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.08.022 · Cited by 17
Fox, C., Bernardino, L., Cochran, J., et al. (2017) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2017.135 · Cited by 16
Cortés, Y. I., Catov, J. M., Brooks, M. M., Harlow, S. D., Isasi, C. R., Jackson, E. A., Matthews, K. A., Thurston, R. C., & Barinas‐Mitchell, E. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007138 · Cited by 16
Dworacka, M., Chukanova, G., Iskakova, S., Kurmambayev, Y., Wesołowska, A., Frycz, B. A., Jagodziński, P. P., & Dworacki, G. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.02.009 · Cited by 16
Interindividual responses to different exercise stimuli among insulin‐resistant women
Álvarez, C., Ramírez‐Vélez, R., Ramírez‐Vélez, R., Ito, S., Celis-Morales, C. A., García‐Hermoso, A., Rodríguez‐Mañas, L., Lucia, A., & Izquierdo, M. (2018) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13213 · Cited by 19
Noh, D., Lim, Y., Lee, H., et al. (2018) · Molecules · doi:10.3390/molecules23051205 · Cited by 16
Exercise Periodization over the Year Improves Metabolic Syndrome and Medication Use
Morales‐Palomo, F., Ramírez-Jiménez, M., ORTEGA, J. F., & Mora‐Rodríguez, R. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001659 · Cited by 17
Martin, B. L., Thompson, L. C., Kim, Y. H., Williams, W. C., Snow, S. J., Schladweiler, M. C. J., Phillips, P. M., King, C. J., Richards, J. H., Haykal-Coates, N., et al. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.06.089 · Cited by 16
Rohini, A., Agrawal, N., Kumar, H., et al. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.08.001 · Cited by 16
Kim, K. E., Heo, J. S., Han, S., Kwon, S., Kim, S., Kim, J., Baek, K., & Sheen, Y. H. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.07.042 · Cited by 15
Cheng, Y., Huang, X., Wu, D., Liu, Q., Zhong, M., Liu, T., Zhang, X., Zhang, G., Hu, S., & Liu, S. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3520-5 · Cited by 17
An association of urinary sodium-potassium ratio with insulin resistance among Korean adults
Park, Y. M., Kwock, C. K., Park, S., Eicher‐Miller, H. A., & Yang, Y. J. (2018) · Nutrition Research and Practice · doi:10.4162/nrp.2018.12.5.443 · Cited by 16
Metwalley, K. A., Farghaly, H. S., & Abdelhamid, A. (2018) · Hormone Research in Paediatrics · doi:10.1159/000492900 · Cited by 16
Higher intakes of energy-adjusted dietary amino acids are inversely associated with obesity risk
Okekunle, A. P., Wu, X., Feng, R., Li, Y., & Sun, C. (2018) · Amino Acids · doi:10.1007/s00726-018-2672-x · Cited by 20
Neves, J. S., Guerreiro, V. A., Carvalho, D. M., Serrão, R., Sarmento, A., & Freitas, P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00681 · Cited by 16
Yıldız, M., Özdemir, N., Önal, H., Koç, B., Tipici, B. E., & Zülfikar, B. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2018.2018.0292 · Cited by 16
Darwish, L., Nguyen, M., Saleem, M., Eakin, K. A., Herrmann, N., Sugamori, K. S., OH, P. I., Yang, P., Mitchell, J., Lanctôt, K. L., et al. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.01.003 · Cited by 19
Pinto, S. L., da Silva, D. C. G., & Bressan, J. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03749-z · Cited by 18
Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study
Kim, G., Lee, S., Lee, B., Kang, E. S., Soo, B., Ferrannini, E., Lee, Y., & Cho, N. H. (2019) · Diabetologia · doi:10.1007/s00125-019-4829-x · Cited by 17
Francini‐Pesenti, F., Querin, G., Martini, C. E., Mareso, S., & Sacerdoti, D. (2018) · Europe PMC (PubMed Central) · Cited by 16
Jacob, K. J., Chevalier, S., Lamarche, M., & Morais, J. A. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz038 · Cited by 20
Oliveira‐Santos, J., Santos, R., Moreira, C. M. M., Abreu, S., Lopes, L., Agostinis‐Sobrinho, C., Stratton, G., & Mota, J. A. P. S. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.05.052 · Cited by 16
Metabolic effects of Ramadan fasting in patients at high risk of cardiovascular diseases
Beltaïef, K., Bouida, W., Trabelsi, I., Baccouche, H., Sassi, M., Dridi, Z., Chakroun, T., Hellara, I., Boukef, R., Hassine, M., et al. (2019) · International Journal of General Medicine · doi:10.2147/ijgm.s172341 · Cited by 17
Kimura, T., Ueno, T., Doi, S., Nakashima, A., Doi, T., Ashitani, A., Kawano, R., Yamane, K., & Masaki, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218290 · Cited by 16
Yetim, A., Baş, F., Yetim, Ç., Uçar, A., Poyrazoğlu, Ş., Bundak, R., & Darendelıler, F. (2019) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1808-52 · Cited by 16
de Lima, T. R., González‐Chica, D. A., Moreno, Y. M. F., & Silva, D. A. S. (2019) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2019-0515 · Cited by 16
Johansson, H.-E., Edholm, D., Kullberg, J., Rosqvist, F., Rudling, M., Straniero, S., Karlsson, F. A., Ahlström, H. K., Sundbom, M., & Risérus, U. (2019) · Nutrition and Diabetes · doi:10.1038/s41387-019-0100-2 · Cited by 18
The natural course of non-alcoholic fatty liver disease
Seval, G. C., Kabacam, G., Yakut, M., et al. (2020) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2020.0008 · Cited by 16
Zupo, R., Castellana, F., Sardone, R., et al. (2020) · Nutrients · doi:10.3390/nu12020474 · Cited by 16
Guevara‐Aguirre, J., Terán, E., Lescano, D., Guevara, A., Guevara, C., Longo, V. D., & Gavilanes, A. W. D. (2020) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2020.02.004 · Cited by 16
Kakutani‐Hatayama, M., Kadoya, M., Morimoto, A., Miyoshi, A., Kosaka‐Hamamoto, K., Kusunoki, Y., Shoji, T., & Koyama, H. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100033 · Cited by 16
Liu, Y., Ma, C., Lv, L., Li, P., Ma, C., He, S., Zeng, J., Ping, F., Zhang, H., Li, W., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5384909 · Cited by 17
Common mechanisms for type 2 diabetes and psychosis: Findings from a prospective birth cohort
Perry, B. I., Jones, H. J., Richardson, T. G., Zammit, S., Wareham, N. J., Lewis, G., Jones, P. B., & Khandaker, G. M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.08.006 · Cited by 16
Maeng, H. J., Lee, G. Y., Bae, J. H., & Lim, S. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186836 · Cited by 16
Effect of hypoxic exercise on glucose tolerance in healthy and prediabetic adults
Groote, E. D., Britto, F. A., Balan, E., Warnier, G., Thissen, J., Nielens, H., Sylow, L., & Deldicque, L. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00263.2020 · Cited by 16
Kim, W., Park, S. K., & Kim, Y. L. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0078 · Cited by 17
Naufel, M. F., Pedroso, A. P., Oyama, L. M., Telles, M. M., Hachul, H., & Ribeiro, E. B. (2021) · Scientific Reports · doi:10.1038/s41598-021-84431-2 · Cited by 18
Correlation between Serum Lipid Parameters and Interleukin-10 Concentration in Obese Individuals
Kim, S., Lim, J., Nam, G. E., & Park, H. S. (2021) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20122 · Cited by 16
Furuhashi, M., Higashiura, Y., Koyama, M., Tanaka, M., Murase, T., Nakamura, T., Akari, S., Sakai, A., Mori, K., Ohnishi, H., et al. (2021) · Hypertension Research · doi:10.1038/s41440-021-00679-1 · Cited by 16
Grădinaru, D., Margina, D. M., Ungurianu, A., Nițulescu, G., Peña, C. D. L., Ionescu-Tirgoviste, C., & Miulescu, R. D. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10829 · Cited by 16
Wei, Y., Tian, Q., Zhao, X., & Wang, X. (2015) · Europe PMC (PubMed Central) · Cited by 16
Liu, C.-M. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i45.7159 · Cited by 16
Viswanathan, V., Clementina, M., Nair, B. M., & Satyavani, K. (2007) · PubMed · Cited by 16
Efeito da perda de peso sobre a hemodinâmica renal em portadores da síndrome metabólica
Ezequiel, D. G. A., Costa, M. B., Chaoubah, A., & de Paula, R. B. (2012) · Brazilian Journal of Nephrology · doi:10.1590/s0101-28002012000100006 · Cited by 16
Pei, D., Kuo, S.-W., Wu, D., Lin, T., Hseih, M.-C., Lee, C., Hsu, W.-L., Chen, S.-P., Sheu, W. H., & Jc, L. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00661.x · Cited by 16
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
